BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 7326723)

  • 1. [Nandrolone decanoate administered to patients with Gynaecomastia (author's transl)].
    Heresová J; Hampl R; Kuska L; Stárka L
    Cas Lek Cesk; 1981; 120(52):1602-5. PubMed ID: 7326723
    [No Abstract]   [Full Text] [Related]  

  • 2. Double-blind placebo-controlled trial of treatment of osteoporosis with the anabolic nandrolone decanoate.
    Need AG; Nordin BE; Chatterton BE
    Osteoporos Int; 1993; 3 Suppl 1():218-22. PubMed ID: 8461566
    [No Abstract]   [Full Text] [Related]  

  • 3. Double-blind placebo--controlled trial of nandrolone decanoate in postmenopausal osteoporosis.
    Chhaparwal M; Saraf ML
    Indian J Med Sci; 1998 Jun; 52(6):236-8. PubMed ID: 9849033
    [No Abstract]   [Full Text] [Related]  

  • 4. Nandrolone decanoate therapy for anemia in patients on haemodialysis.
    Balaji HD; Hariharan S; Jacob CK; Kirubakaran MG; Shastry JC
    J Assoc Physicians India; 1988 Nov; 36(11):677-8. PubMed ID: 3074079
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of nandrolone decanoate on the lipid profile of male peritoneal dialysis patients.
    Mora C; Macía ML; García J; Navarro JF
    Perit Dial Int; 2001; 21(6):611-4. PubMed ID: 11783772
    [No Abstract]   [Full Text] [Related]  

  • 6. Cross-over study of fat-corrected forearm mineral content during nandrolone decanoate therapy for osteoporosis.
    Need AG; Horowitz M; Walker CJ; Chatterton BE; Chapman IC; Nordin BE
    Bone; 1989; 10(1):3-6. PubMed ID: 2736154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prophylaxis and treatment of osteoporosis].
    Kopera H
    Klin Wochenschr; 1989 May; 67(10):557-8. PubMed ID: 2739351
    [No Abstract]   [Full Text] [Related]  

  • 8. Nandrolone decanoate; use in HIV-associated lipodystrophy syndrome: a pilot study.
    Gold J; Batterham M
    Int J STD AIDS; 1999 Aug; 10(8):558. PubMed ID: 10471109
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of resistance exercise training and nandrolone decanoate on body composition and muscle function among patients who receive hemodialysis: A randomized, controlled trial.
    Johansen KL; Painter PL; Sakkas GK; Gordon P; Doyle J; Shubert T
    J Am Soc Nephrol; 2006 Aug; 17(8):2307-14. PubMed ID: 16825332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A controlled trial of nandrolone decanoate in the treatment of rheumatoid arthritis in postmenopausal women.
    Bird HA; Burkinshaw L; Pearson D; Atkinson PJ; Leatham PA; Hill J; Raven A; Wright V
    Ann Rheum Dis; 1987 Mar; 46(3):237-43. PubMed ID: 3555359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anabolic steroids and osteoporosis.
    Dequeker J; Geusens P
    Acta Endocrinol Suppl (Copenh); 1985; 271():45-52. PubMed ID: 3865481
    [No Abstract]   [Full Text] [Related]  

  • 12. Androgens, erythropoietin, iron stores, and lipoprotein (a) in hemodialysis patients.
    Fourtounas C; Tzanatos H; Fourtounas C; Kopelias I; Agroyannis B
    Am J Kidney Dis; 1997 Dec; 30(6):935-6. PubMed ID: 9398146
    [No Abstract]   [Full Text] [Related]  

  • 13. Nandrolone decanoate: pharmacological properties and therapeutic use in osteoporosis.
    Geusens P
    Clin Rheumatol; 1995 Sep; 14 Suppl 3():32-9. PubMed ID: 8846659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nutritional effect of nandrolone decanoate in predialysis patients with chronic kidney disease.
    Eiam-Ong S; Buranaosot S; Eiam-Ong S; Wathanavaha A; Pansin P
    J Ren Nutr; 2007 May; 17(3):173-8. PubMed ID: 17462549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects on the bones of nandrolone decanoate therapy in postmenopausal osteoporosis].
    Gennari C; Agnusdei D; Gonnelli S
    Minerva Endocrinol; 1989; 14(1):69-74. PubMed ID: 2659955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of nandrolone decanoate compared with placebo or testosterone on HIV-associated wasting.
    Gold J; Batterham MJ; Rekers H; Harms MK; Geurts TB; Helmyr PM; Silva de Mendonça J; Falleiros Carvalho LH; Panos G; Pinchera A; Aiuti F; Lee C; Horban A; Gatell J; Phanuphak P; Prasithsirikul W; Gazzard B; Bloch M; Danner SA;
    HIV Med; 2006 Apr; 7(3):146-55. PubMed ID: 16494628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beneficial effects of nandrolone decanoate in wasting associated with HIV.
    Saha B; Rajadhyaksha GC; Ray SK
    J Indian Med Assoc; 2009 May; 107(5):295-9. PubMed ID: 19886384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of anabolic steroids on diaphragm impairment induced by methylprednisolone in emphysematous hamsters.
    van Balkom RH; Dekhuijzen PN; van der Heijden HF; Folgering HT; Fransen JA; van Herwaarden CL
    Eur Respir J; 1999 May; 13(5):1062-9. PubMed ID: 10414405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nandrolone decanoate reduces the premature mortality of cardiomyopathic hamsters.
    Davis WM; Long SF; Lin TL
    Res Commun Chem Pathol Pharmacol; 1993 Jul; 81(1):21-32. PubMed ID: 8210687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beneficial effects of an anabolic steroid during cytotoxic chemotherapy for metastatic cancer.
    Spiers AS; DeVita SF; Allar MJ; Richards S; Sedransk N
    J Med; 1981; 12(6):433-45. PubMed ID: 7033426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.